[3] Kingwell BA，Chapman MJ，Kontush A，et al. HDL-targeted therapies：progress，failures and future [J]. Nat Rev Drug Discov，2014，13(6)：445-464.

    [4] Siddiqi HK，Kiss D，Rader D. HDL-cholesterol and cardiovascular disease：rethinking our approach [J]. Curr Opin Cardiol，2015，30(5)：536-542.

    [5] Shimizu T，Miura SI，Tanigawa H，et al. Rosuvastatin activates ATP-binding cassette transporter A1-dependent efflux ex vivo and promotes reverse cholesterol transport in macrophage cells in mice fed a high-fat diet [J]. Arterioscl Throm Vas Biol ......